Home Translational Medicine Biomarkers

Biomarkers

Latest
Biomarkers

Major Depressive Disorder Study Identifies Promising Biomarker for High Risk Individuals

TBI
Biomarkers

Exosome Therapy for Stroke Produces Full Recovery in Animal Model

ELISA immuno assay reaction
Biomarkers

Get Fired Up about Multiplexed Biomarker Profiling

dna molecules on abstract technology background
Biomarkers

DNA Has Relatively Little Say in Disease Risk (Usually)

exosome
Biomarkers

Gene Therapy Method Transforms Human Cells into Mass Producers of Potential...

Acoustofluidics Saliva Test Shows Promise for Earlier and Easier Detection of Mouth and Throat Cancer
Biomarkers

Saliva-Based Test Detects Presence of Human Papillomavirus

Biomarkers

Human Genes 10% More Numerous, If You Count smORFs

Biomarkers

Measuring Cancer’s Response to Treatment with a Liquid Biopsy Kit

At Left. A multiplexed pharmacodynamics assay was developed recently to assess immune checkpoint inhibitor–targeted CD8 activation and tumor colocalization in formalin-fixed paraffin-embedded tissues. The assay, which used oligo-conjugated antibodies supplied by Ultivue, achieved multiplex staining of CD8 (red), CD3z-pY142 (yellow), β-catenin (cyan), and Zap70-pY493 (not shown) on bead-activated CD3 cells from tissue spiked with interferon-γ-induced ACHN tumor cell lines. Staining of β-catenin allowed tumor cells to be differentiated from immune cells. Arrows point to CD8 cells that are CD3z-pY142+, indicating T-cell receptor activation.
Biomarkers

Biomarker Specialists Team Up, Run Up the Companion Diagnostics Score

Rectal cancer cell
Biomarkers

Synthetic Biomaterial Scaffold Could Serve as Early Cancer Diagnostic

Load more

GEN Edge

Recently Featured

Copyright © 2020 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up